InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Katkin Keith, Director. Officer active across 4 companies, notably RIGEL PHARMACEUTICALS INC. Cumulatively, 5 reports have been recorded. The latest transaction was disclosed on 2 April 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
08,595 shares0
Common Stock
SEC:0001367644-22-000061:0·
016,000 shares0
Common Stock
SEC:0001562180-22-001074·
016,000 shares0
Common Stock
SEC:0001562180-22-001074:0·
025,000 shares0
Common Stock
SEC:0001179110-21-005767·
025,000 shares0
Common Stock
SEC:0001179110-21-005767:0·
5 of 5 declarations
About Katkin Keith
Keith Katkin serves as a Director for RIGEL PHARMACEUTICALS INC and Syndax Pharmaceuticals Inc. In these roles, he contributes to corporate governance and strategic decision-making. His expertise in the pharmaceutical sector allows him to make significant contributions to the leadership of these companies.
